Nemagen

Developer of therapies for allergic inflammation and mast cell-related diseases

placeCranbury, New Jersey, United States calendar_todayFounded 2019 groups3 employees language nemagen.com

Social engagement

Social engagement: 290 social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%

Recent activity

11 Sep 2025
Milestone
users
Coming soon